Manufacture of Asymmetric Hydrogenation Catalysts - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Manufacture of Asymmetric Hydrogenation Catalysts
Single-enantiomer drugs represent an increasingly large share of new chemical entities, leading to approaches in asymmetric synthesis.


Pharmaceutical Technology


14. M.J. Burk, "C2-Symmetric Bis(phospholanes) and their Use in Highly Enantioselective Hydrogenation Reactions," J. Am. Chem. Soc. 113 (22), 8518–8519 (1991).

15. S.J.C. Taylor et al., "Choice of Biocatalyst in the Development of Industrial Biotransformations," in Stereoselective Biocatalysis, R.N. Patel, Ed. (Marcel Dekker, New York, 2000), p. 397–413.

16. U. Berens, "Process for Preparing Cyclic Phosphines," US Patent 6545183, 1999.

17. U. Berens, M.J. Burk, and A. Gerlach, "Chiral 1,1-Diphosphetanylferrocenes: New Ligands for Asymmetric Catalytic Hydrogenation of Itaconate Derivatives," Angew. Chem. Int. Ed. 39 (11), 1981–1984 (2000).

18. M.Green, T.A. Kuc, and S.H.J. Taylor, J. Chem. Soc (D) Chem. Comm. (22), 1553–1554 (1970).

19. J.A. Ramsden and P.H. Moran, "Process for Preparting Catonic Rhodium Complexes," Patent WO 2005032712, Chem. Abstr. 142, 394141 (2005).

20. I. Appleby, I. et. al., "Efficient Synthesis of an Imidazole-Substituted δ-Amino Acid by the Integration of Chiral Technologies," Org. Lett. 7 (10), 1931–1934 (2005).

21. D. Chaplin et al., "Industrially Viable Syntheses of Highly Enantiomerically Enriched 1-Aryl Alcohols via Asymmetric Hydrogenation," Org. Process Res. Dev. 7 (1), 89–94 (2003).

22. H. Doucet, et al., "Trans-[RuCl2(phosphane)2(1,2-diamine)] and Chiral trans-[RuCl2 (diphosphane)(1,2-diamine)]: Shelf-Stable Precatalysts for the Rapid, Productive, and Stereoselective Hydrogenation of Ketones," Angew. Chem. Int. Ed. 37 (12), 1703–1707 (1998).

23. P.H.Moran, "Process for Making Diphosphine-Ruthenium Diamine Complexes," WO Patent 2007005550, Chem. Abstr. 146, 133961 (2007).

24. M.T. Reetz and X. Li, "An Efficient Catalyst System for the Asymmetric Transfer Hydrogenation of Ketones: Remarkably Broad Substrate Scope," J. Am. Chem. Soc. 128 (4), 1044–1045 (2006).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
27%
Attracting a skilled workforce
27%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
32%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Source: Pharmaceutical Technology,
Click here